A novel pyridine-based Schiff base with multi-target pharmacological potential: Synthesis, biological evaluation, and molecular docking analysis
Turkish Journal of Analytical Chemistry · 31.05.2026 · 8 (2) · 85-93
DOI: 10.51435/turkjac.1872743 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Analytical Chemistry, online erschienen am 31.05.2026. Verfasst von Fatih Çelik und 4 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
In the present study, a novel Schiff base derived from pyridine-4-carboxaldehyde and 4-aminobutan-1-ol was synthesized via a condensation reaction and purified by recrystallization from a DMF/water solvent system. The compound was characterized by IR, 1H-NMR, and 13C-NMR studies. The pharmacological potential of a synthesized compound was evaluated through cell viability and enzyme inhibition assays. The compound exhibited selective cytotoxicity toward MCF-7 breast cancer cells compared to non-tumorigenic MCF-10A cells, with IC₅₀ values of 6.5 mM and 21.8 mM, respectively. In enzyme inhibition studies, the compound showed dose-dependent inhibitory activity against HIV-1 reverse transcriptase, acetylcholinesterase, and α-glucosidase, with IC₅₀ values ranging from 11 to 14 mM. Notably, HIV-1 RT displayed higher sensitivity at lower concentrations. These findings suggest that the compound has multi-target pharmacological potential and may serve as a promising lead for further investigation. Molecular docking was employed to evaluate the binding behavior of a newly synthesized Compound I against HIV-1 reverse transcriptase, epidermal growth factor receptor, and acetylcholinesterase. Docking results revealed that Compound I exhibited moderate binding affinity toward all three targets, with a relative preference for acetylcholinesterase, as evidenced by favorable binding energies and key intermolecular interactions. Although its predicted affinities were lower than those of established reference inhibitors, Compound I demonstrated stable binding orientations and conserved interaction patterns within the active sites. These findings suggest that Compound I may serve as a promising lead scaffold for further structure-based optimization.
Zitieren
APA
Çelik, F., Senocak, A. N., Güler, H. İ., Bektaş, K. İ., & Ünver, Y. (2026). A novel pyridine-based Schiff base with multi-target pharmacological potential: Synthesis, biological evaluation, and molecular docking analysis. Turkish Journal of Analytical Chemistry, 8(2), 85-93. https://doi.org/10.51435/turkjac.1872743
Vancouver
Çelik F, Senocak AN, Güler Hİ, Bektaş Kİ, Ünver Y. A novel pyridine-based Schiff base with multi-target pharmacological potential: Synthesis, biological evaluation, and molecular docking analysis. Turkish Journal of Analytical Chemistry. 2026;8(2):85-93. doi:10.51435/turkjac.1872743
BibTeX
@article{elik2026,
author = {Çelik, Fatih and Senocak, Aleyna Nalcaoglu and Güler, Halil İbrahim and Bektaş, Kadriye İnan and Ünver, Yasemin},
title = {A novel pyridine-based Schiff base with multi-target pharmacological potential: Synthesis, biological evaluation, and molecular docking analysis},
journal = {Turkish Journal of Analytical Chemistry},
year = {2026},
volume = {8},
number = {2},
pages = {85--93},
doi = {10.51435/turkjac.1872743}
}
EUVIMED